16LBA VEGFR-1 polymorphisms as potential predictors of clinical outcome in bevacizumab-treated patients with metastatic pancreatic cancer

Diether Lambrechts; Paul Delmar; Ian Buysschaert; Bart Claes; Betül T. Yesilyurt; Chris Verslype; Dorothee Foernzler; Peter Carmeliet; Sameul Scherer; Eric Van Cutsem

doi:10.1016/s1359-6349(09)72051-8

Related publications

Article2014

Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer

George Pentheroudakis, Vassiliki Kotoula, George Kouvatseas, Elpida Charalambous, Dimitrios Dionysopoulos, Flora Zagouri, Αngelos Koutras, Konstantinos Papazisis, Dimitrios Pectasides, Epaminontas Samantas, Meletios A Dimopoulos, Christos N. Papandreou, George Fountzilas

Article2011

1414 POSTER Single Nucleotide Polymorphism Analysis and Outcome in Advanced-stage Cancer Patients Treated With Bevacizumab

Diether Lambrechts, Paul Delmar, D.W. Miles, N. B. Leighl, Leonard B. Saltz, Bernard Escudier, Eric Van Cutsem, S.J. Scherer, Peter Carmeliet, Sanne de Haas

Article2011

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer

George Fountzilas, D. Pectasides, Ioannis Efstratiou, Dimitra Repana, Evangelia Razis, Kostas Papazisis, Meletios A Dimopoulos, Christos N. Papandreou, C. Papadimitriou, Despina Televantou, Pavlos Papakostas, Gerasimos Aravantinos, George Pentheroudakis, Dimitrios Bafaloukos, Kalliopi Petraki, Constantina Christodoulou, Αngelos Koutras, Dimosthenis Miliaras, H. Kourea, Mattheos Bobos, Vasiliki Kotoula-Dimitriadou, Eleni Timotheadou

Article2024

Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab

Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Federico Rossari, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Iavarone,

Article2017

Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib

Eri Banno, Yosuke Togashi, Marco A. De Velasco, Takuro Mizukami, Yu Nakamura, Masato Terashima, Kazuko Sakai, Yoshihiko Fujita, Ken Kamata, Masayuki Kitano, Masatoshi Kudo, Kazuto Nishio